› Forums › General Melanoma Community › New molecule DEL-22379 unaffected by resistance that hamper BRAF/MEK inhibitors
- This topic has 6 replies, 2 voices, and was last updated 9 years, 9 months ago by
bjorne.
- Post
-
- August 18, 2015 at 8:58 am
I found this Cell article, I found it very interesting and I would like to share it with you all, maybe someone with more knowledge, or contacts with MD doctors or researches could give a read.
http://www.cell.com/cancer-cell/abstract/S1535-6108(15)00253-6
it sounds promising as it follows a new (at least for me) concept of treatment. I hope that someone can put this in MD o Researchers hands.
"The strategy is decoupling molecular interactions in a key point in the chain of transmission. This is what achieves the DEL-22379 molecule that prevents teh association (dimerization) between two proteins ERK.
Thank you all
Husband
- Replies
-
-
- August 18, 2015 at 12:39 pm
The link to the article doesn't work bjorne.
-
- August 18, 2015 at 12:39 pm
The link to the article doesn't work bjorne.
-
- August 18, 2015 at 12:39 pm
The link to the article doesn't work bjorne.
-
- August 18, 2015 at 10:09 pm
Sorry, I do not know how to edit the previous post, here is:
http://www.cell.com/cancer-cell/abstract/S1535-6108(15)00253-6
-
- August 18, 2015 at 10:09 pm
Sorry, I do not know how to edit the previous post, here is:
http://www.cell.com/cancer-cell/abstract/S1535-6108(15)00253-6
-
- August 18, 2015 at 10:09 pm
Sorry, I do not know how to edit the previous post, here is:
http://www.cell.com/cancer-cell/abstract/S1535-6108(15)00253-6
-
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.